Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints, and clinical evidence

Hughes, Stephen; Livermore, David M.; Boyd, Sara E.; Kahlmeter, Gunnar; Teale, Christopher; Burns, Phillipa; Brown, Nicholas M.; MacGowan, Alasdair

doi:10.1093/jac/dkag051

Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints, and clinical evidence

Tools

Hughes, Stephen, Livermore, David M. ORCID: https://orcid.org/0000-0002-9856-3703, Boyd, Sara E., Kahlmeter, Gunnar, Teale, Christopher, Burns, Phillipa, Brown, Nicholas M. and MacGowan, Alasdair (2026) Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints, and clinical evidence. Journal of Antimicrobial Chemotherapy, 81 (3). ISSN 0305-7453

[thumbnail of Cefalexin dosing and evidence gaps in pyelonephritisJAC2025]

Microsoft Word (OpenXML) (Cefalexin dosing and evidence gaps in pyelonephritisJAC2025) - Accepted Version
Available under License Creative Commons Attribution.
Download (76kB)

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:	https://www.scopus.com/pages/publication...
Depositing User:	LivePure Connector
Date Deposited:	23 Jan 2026 14:30
Last Modified:	30 Jul 2026 14:22
URI:	https://ueaeprints.uea.ac.uk/id/eprint/101693
DOI:	10.1093/jac/dkag051

Downloads

Downloads per month over past year

Actions (login required)

View Item